Table 1.
Characteristics | Number of patients n = 279 (%) |
---|---|
Age (continuous) | |
Median (range) | 65.5 (34.2-79.3) |
Age (categorical) | |
<75 | 257 (92.1) |
≥75 | 22 (7.9) |
Sex | |
Male | 187 (67.0) |
Female | 92 (33.0) |
Histology | |
Adenocarcinoma | 273 (97.9) |
NOS carcinoma | 6 (2.1) |
Large cell lung cancer | 0 (0.0) |
Adenosquamous | 0 (0.0) |
Squamous | 0 (0.0) |
Unknown—N/D | 0 |
EGFR status known | |
Yes | 279 (100.0) |
No | 0 (0.0) |
EGFR mutation | |
Negative | 279 (100.0) |
ALK status known | |
Yes | 279 (100.0) |
No | 0 (0.0) |
ALK status known | |
Negative | 279 (100.0) |
PDL1 | |
<1% | 123 (44.1) |
1%–49% | 156 (55.9) |
≥50% | 0 |
PS ECOG | |
0 | 107 (39.5) |
1 | 148 (54.6) |
2 | 16 (5.9) |
Unknown | 8 |
Smoking history | |
Ex-smoker | 59 (41.8) |
Smoker | 49 (34.8) |
Not smoker | 33 (23.4) |
Unknown | 138 |
Presence of brain metastases | |
Yes | 48 (17.6) |
No | 225 (82.4) |
Unknown | 6 |
Percentages reported in the table were calculated using the number of patients with available data (for each variable).